+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical trial registration: a step forward in providing transparency for the positive and negative results of clinical trials



Clinical trial registration: a step forward in providing transparency for the positive and negative results of clinical trials



Archives of Dermatology 141(1): 75




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048558739

Download citation: RISBibTeXText

PMID: 15655145

DOI: 10.1001/archderm.141.1.75


Related references

Transparency in clinical research: registration of clinical trials and publication of results. Medicina Clinica 139(13): 593-597, 2012

Registration of clinical trials: a step forward but still a long path ahead. Haematologica 91(3): 295-296, 2006

Mandatory registration of clinical trials: a major step forward for evidence-based medicine. Journal of the American Academy of Dermatology 52(5): 890-892, 2005

Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency. Revista Panamericana de Salud Publica 30(1): 87-96, 2011

Transparency of Outcome Reporting and Trial Registration of Randomized Controlled Trials Published in the Journal of Consulting and Clinical Psychology. Plos one 10(11): E0142894, 2015

Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States. Bmj Open 7(9): E015110, 2017

Clinical trials: registration and transparency. European Respiratory Journal 47(5): 1342-1344, 2016

Clinical trials transparency and the Trial and Experimental Studies Transparency (TEST) act. Contemporary Clinical Trials 37(2): 219-224, 2014

Clinical and polysomnographic features in DQB1*0602 positive and negative narcolepsy patients: results from the modafinil clinical trial. Sleep Medicine 1(1): 33-39, 2000

One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI). Journal of Alzheimer's Disease 69(1): 1-2, 2019

Clinical trial transparency: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved recently in Europe. Current Medical Research and Opinion 30(3): 395-405, 2014

European Union Clinical Trials Register: on the way to more transparency of clinical trial data. Expert Review of Clinical Pharmacology 6(5): 457-459, 2013

Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2014. Current Medical Research and Opinion 34(7): 1239-1243, 2018

Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2013. Current Medical Research and Opinion 33(3): 473-478, 2017

Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2012. Current Medical Research and Opinion 31(7): 1431-1435, 2015